Immediate Impact
2 by Nobel laureates 13 from Science/Nature 66 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Works of Frank Herting being referenced
Antitumour activity of the glycoengineered type II anti‐CD 20 antibody obinutuzumab (GA 101) in combination with the MDM 2‐selective antagonist idasanutlin (RG 7388)
2016
Ang-2-VEGF-A CrossMab, a Novel Bispecific Human IgG1 Antibody Blocking VEGF-A and Ang-2 Functions Simultaneously, Mediates Potent Antitumor, Antiangiogenic, and Antimetastatic Efficacy
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Frank Herting | 314 | 177 | 193 | 229 | 28 | 700 | |
| Giovanni Citterio | 250 | 115 | 64 | 337 | 36 | 842 | |
| Patrick B. Lappin | 286 | 53 | 126 | 174 | 26 | 660 | |
| Rosa I. Gallagher | 410 | 140 | 158 | 341 | 27 | 792 | |
| Milos J. Janicek | 171 | 138 | 99 | 295 | 18 | 583 | |
| Y. Terui | 328 | 71 | 55 | 206 | 28 | 674 | |
| Maxim Kebenko | 240 | 61 | 101 | 260 | 29 | 590 | |
| Carsten Dan Ley | 299 | 173 | 136 | 115 | 25 | 707 | |
| Glenn Michelson | 333 | 78 | 76 | 278 | 50 | 649 | |
| Ivan Inigo | 219 | 111 | 87 | 357 | 21 | 675 | |
| Shenghua Wen | 392 | 40 | 108 | 198 | 21 | 603 |
All Works
Loading papers...